Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Revenue

Tango Therapeutics had revenue of $56.99M in the twelve months ending March 31, 2026, up 60.09% year-over-year. In the year 2025, Tango Therapeutics had annual revenue of $62.38M with 48.29% growth.

• Revenue (ttm): $56.99M
• Revenue Growth: +60.09%
• P/S Ratio: 83.50
• Revenue / Employee: $416,000
• Employees: 137
• Market Cap: 4.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.38M	20.32M	48.29%
Dec 31, 2024	42.07M	5.54M	15.17%
Dec 31, 2023	36.53M	11.67M	46.93%
Dec 31, 2022	24.86M	-12.18M	-32.89%
Dec 31, 2021	37.04M	29.39M	383.83%
Dec 31, 2020	7.66M	-16.99M	-68.94%
Dec 31, 2019	24.65M	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error